HSBC Holdings
RGNX icon

HSBC Holdings’s Regenxbio RGNX Stock Holding History

HSBC Holdings’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Buy
55,830
+12,391
+29% +$130K ﹤0.01% 2252
2025
Q4 		$618K Sell
43,439
-32,892
-43% -$410K ﹤0.01% 2201
2025
Q3 		$745K Sell
76,331
-14,473
-16% -$128K ﹤0.01% 1918
2025
Q2 		$745K Buy
90,804
+34,989
+63% +$293K ﹤0.01% 1951
2025
Q1 		$390K Sell
55,815
-29,002
-34% -$216K ﹤0.01% 2212
2024
Q4 		$629K Buy
84,817
+48,310
+132% +$454K ﹤0.01% 2047
2024
Q3 		$376K Buy
36,507
+16,591
+83% +$202K ﹤0.01% 2182
2024
Q2 		$234K Buy
19,916
+5,389
+37% +$83.9K ﹤0.01% 2452
2024
Q1 		$306K Sell
14,527
-13,618
-48% -$242K ﹤0.01% 2431
2023
Q4 		$504K Sell
28,145
-2,437
-8% -$42.9K ﹤0.01% 2051
2023
Q3 		$511K Sell
30,582
-6,889
-18% -$125K ﹤0.01% 1985
2023
Q2 		$757K Buy
37,471
+6,391
+21% +$123K ﹤0.01% 1828
2023
Q1 		$578K Buy
31,080
+14,585
+88% +$323K ﹤0.01% 1990
2022
Q4 		$368K Buy
16,495
+4,276
+35% +$96.7K ﹤0.01% 2429
2022
Q3 		$328K Buy
12,219
+3,813
+45% +$113K ﹤0.01% 2368
2022
Q2 		$210K Sell
8,406
-1,127
-12% -$28.2K ﹤0.01% 2862
2022
Q1 		$321K Buy
+9,533
New +$265K ﹤0.01% 2710
2021
Q3 		– Sell
-7,788
Closed -$308K – 3135
2021
Q2 		$308K Sell
7,788
-6,275
-45% -$224K ﹤0.01% 2497
2021
Q1 		$480K Buy
+14,063
New +$600K ﹤0.01% 1992
2020
Q3 		– Sell
-44,578
Closed -$1.64M – 2833
2020
Q2 		$1.64M Buy
+44,578
New +$1.66M ﹤0.01% 1234
2020
Q1 		– Sell
-5,283
Closed -$217K – 2973
2019
Q4 		$217K Sell
5,283
-1,738
-25% -$68.7K ﹤0.01% 2763
2019
Q3 		$250K Buy
7,021
+883
+14% +$35.8K ﹤0.01% 2752
2019
Q2 		$316K Buy
6,138
+829
+16% +$41.4K ﹤0.01% 2292
2019
Q1 		$304K Buy
+5,309
New +$263K ﹤0.01% 2331

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's RGNX Position: Q1 2026 in Review

HSBC Holdings increased its Regenxbio (RGNX) stake by 29% in Q1 2026, buying an estimated $130K and bringing the position to 55,830 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

HSBC Holdings first reported a position in RGNX in Q1 2019 and has held it in 24 quarters since. The position peaked at $1.64M in Q2 2020. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • HSBC Holdings held 55,830 shares of Regenxbio worth $467K as of Q1 2026.
  • HSBC Holdings bought 12,391 Regenxbio shares in Q1 2026, an estimated $130K.
  • Regenxbio made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2252 holding.
  • HSBC Holdings first reported a position in Regenxbio in Q1 2019 and has held it in 24 quarters since.
  • HSBC Holdings's Regenxbio position peaked at $1.64M in Q2 2020.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.